Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
53.54
-1.09 (-2.00%)
At close: Nov 4, 2024, 4:00 PM
53.75
+0.21 (0.39%)
After-hours: Nov 4, 2024, 7:55 PM EST

Moderna Revenue

Moderna had revenue of $241.00M in the quarter ending June 30, 2024, a decrease of -29.94%. This brings the company's revenue in the last twelve months to $5.05B, down -52.60% year-over-year. In the year 2023, Moderna had annual revenue of $6.85B, down -64.45%.

Revenue (ttm)
$5.05B
Revenue Growth
-52.60%
P/S Ratio
4.13
Revenue / Employee
$901,786
Employees
5,600
Market Cap
20.58B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20236.85B-12.42B-64.45%
Dec 31, 202219.26B792.00M4.29%
Dec 31, 202118.47B17.67B2,200.25%
Dec 31, 2020803.00M743.00M1,238.33%
Dec 31, 201960.00M-75.07M-55.58%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.